SECOND AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • August 4th, 2008 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations
THIS SECOND AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (this “Second Amendment”) is entered into as of the 26th day of June, 2008 (“Second Amendment Effective Date”) by and between Cubist Pharmaceuticals, Inc., a Delaware corporation (“Cubist”) and Hospira Worldwide, Inc., a Delaware corporation (“Hospira”) to amend the terms of that certain Development and Supply Agreement, as amended, between Abbott Laboratories, predecessor in interest to Hospira, and Cubist (the “Agreement”).
CONFIDENTIAL TREATMENT LICENSE AND COLLABORATION AGREEMENT By and Between Dyax Corp. And Cubist Pharmaceuticals, Inc.,License and Collaboration Agreement • August 4th, 2008 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This License and Collaboration Agreement (this “Agreement”) is made and effective as of April 23, 2008 (the “Effective Date”) by and between Dyax Corp., a Delaware corporation, with offices at 300 Technology Square, Cambridge, Massachusetts 02139, U.S.A. (“Dyax”) and Cubist Pharmaceuticals, Inc., a Delaware corporation, with offices at 65 Hayden Avenue, Lexington, Massachusetts 02421, U.S.A. (“Cubist”).
